A White House proposal to ease the process of researching Schedule I drugs, such as cannabis and psychedelics, has gained a seal of approval from the Drug Enforcement Administration (DEA) and National...

On Thursday, August 31, the Biden administration suggested rule changes to the federal drug scheduling system that could potentially streamline the process of researching Schedule I controlled substances. Included...

Last year, Dr. Rahul Gupta is believed to have consulted with a medical cannabis business in Massachusetts for nine months. Why is this relevant? Because Dr. Gupta is President Joe Biden’s choice to...